Global EditionASIA 中文雙語Fran?ais
    Opinion
    Home / Opinion / Global Lens

    AI sparking a global health revolution

    By Roland Eils and Gu Lei | China Daily | Updated: 2025-05-28 06:52
    Share
    Share - WeChat
    MA XUEJING/CHINA DAILY

    Imagine a world where diseases are spotted before they strike, health is monitored by a digital guardian and treatments are perfectly tailored. This is no longer a distant dream but an emerging reality supercharged by artificial intelligence, big data and digital health. These technologies are rewriting global public health, offering a more reliable way to better predict illnesses, closely monitor people's well-being, treat them with pinpoint accuracy, and make healthcare fairer and faster. To achieve this, we need a strong, equitable worldwide healthcare system.

    Think of AI and big data as health super-sleuths. They sift through mountains of health data, spotting patterns humans might miss, making disease prediction sharper. The large language model of DeepSeek shows promise in understanding medical conversations and helping doctors read scans for early signs of trouble, which means quicker help and access to fairer medical knowhow.

    AI analysis of electronic health records can flag risks which can lead to hundreds of diseases later in life and years before the onset of the disease. This is vital for spotting individuals vulnerable to diseases during health scares. A simple, cheap AI-read eye scan could soon predict the risks for many conditions including type 2 diabetes, making large-scale, cost-effective early disease detection feasible.

    AI-powered wearables and health apps are becoming personal health coaches, tracking body signals, lifestyle and the environment to warn of risks and offer tailored advice. AI analysis of our unique chemical signature readily obtained from a single blood draw can predict multi-disease risk and track health in detail. This proactive approach is key to chronic disease control and boosting health literacy.

    AI also personalizes treatment. By crunching patient data and medical studies, AI can help understand diseases, find new drug targets and predict treatment responses. It can spot patient subgroups who will respond best to specific therapies and help expedite the discovery of new medicines and testing methods, making access to life-saving drugs faster.

    AI, big data and digital health technologies are transforming healthcare, making it more efficient, accessible and equitable. By automating administrative tasks, optimizing hospital work-flows, and supporting faster, more accurate diagnoses, AI reduces the burden on medical workers and shortens patients' wait time. Advanced large language models such as DeepSeek can provide expert-level medical support for remote and underserved regions, helping bridge the gap in access to quality medical care.

    These innovations play a vital role in addressing global healthcare disparities. Low-cost AI-powered health apps and virtual consultations extend high-quality medical services to communities with limited resources. When trained on diverse medical data, AI systems offer accurate predictions for a wide range of population groups, including those historically underrepresented. Affordable diagnostic tools, such as AI-analyzed retinal scans and chemical signature tests, further democratize access to vital health information, paving the way for more inclusive and proactive healthcare worldwide.

    While the promise of AI in healthcare is immense, ensuring its safe, ethical and equitable use requires thoughtful regulation. Regulations for AI in healthcare markedly differs across the European Union, the United States and China. The EU leads with its comprehensive AI Act, classifying health-related AI as high-risk, and requiring strict oversight and compliance. Its General Data Protection Regulation enforces rigorous data privacy, emphasizing individual rights and explicit consent.

    The US lacks a unified AI law, relying on the FDA for case-by-case regulation for AI in healthcare, and the Health Insurance Portability and Accountability Act for data privacy, which is less stringent than the EU's GDPR.

    China, on the other hand, has adopted a strategic, State-guided approach, embedding AI governance within broader national frameworks. While it has no standalone AI law, it issues detailed ethical guidelines and uses the Personal Information Protection Law to regulate health data, emphasizing consent and data localization.

    These different models — the EU's rights-based, the US' innovation-driven, and China's State-coordinated — reflect distinct policy priorities and cultural values shaping the global landscape of AI in healthcare. Given China's rapid pace of AI innovation and strong State coordination, the country is well positioned to accelerate the use of AI-driven healthcare solutions from urban centers to remote rural areas.

    In doing so, China can serve as a global role model by demonstrating how digital health technologies can promote equity and transform public health at scale. We are entering a new era of data-driven, AI-enabled public health. To seize the opportunities offered by this advancement, we need global cooperation, interdisciplinary research and shared ethical principles. By embracing these technologies responsibly and inclusively, we can build a smarter, fairer and healthier world for all.

    Roland Eils is a member of Leopoldina National Academy of Sciences, Germany and is promoting AI healthcare applications in Berlin and Shanghai.
    Gu Lei is a principal investigator, exploring environmental-genetic interactions with the integration of AI at the Max Planck Institute for Heart and Lung Research.

    The views don't necessarily reflect those of China Daily.

    If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn, and comment@chinadaily.com.cn.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    久久亚洲精品成人av无码网站| 中文字幕一区二区三区久久网站 | 婷婷四虎东京热无码群交双飞视频| 刺激无码在线观看精品视频| 中文字幕日韩欧美一区二区| 天堂亚洲国产中文在线| 无码中文人妻视频2019 | 久久久久精品国产亚洲AV无码| 欧美 亚洲 日韩 中文2019| 精品久久无码中文字幕| 最新中文字幕AV无码不卡| 中文字幕在线资源| 亚洲中文字幕无码一区二区三区| yy111111少妇无码影院| 少妇伦子伦精品无码STYLES| 中文有码vs无码人妻| 中文字幕无码av激情不卡久久| 日本中文字幕在线不卡高清| 久クク成人精品中文字幕 | 91在线中文字幕| 亚洲精品无码你懂的网站| 亚洲综合无码一区二区| 免费无码VA一区二区三区| 无码国产精品一区二区免费3p| 曰批全过程免费视频在线观看无码 | 日本中文字幕在线视频一区| 久久精品亚洲中文字幕无码麻豆| 国偷自产短视频中文版| 在线天堂中文WWW官网| 婷婷综合久久中文字幕蜜桃三电影 | 东京热加勒比无码视频| 精品无码AV无码免费专区| 久久精品无码午夜福利理论片| 精品无码国产一区二区三区AV| 人妻无码一区二区三区免费| 久久亚洲精品成人av无码网站| 国产乱人伦Av在线无码| MM1313亚洲精品无码| 亚洲精品无码久久久| 人妻AV中文字幕一区二区三区| 最近中文字幕2019高清免费|